Stock listing
VRAX Stock Price, News, Filings & Events — Virax Biolabs Group Limited
Selected listing: VRAX · NASDAQ · USD · US
VRAX:NASDAQ is the primary listing for Virax Biolabs Group Limited, a public company operating in the US market. With a market capitalization of around $3.02 million, Virax is dedicated to creating innovative healthcare solutions. The company is actively involved in various developments and initiatives within the healthcare sector, reflecting its commitment to addressing emerging health challenges. Recent news and filings may provide insights into its strategic direction and market positioning.
- Ticker
- VRAX:NASDAQ
- Asset type
- Stock
- Market cap
- $2.5M
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- NASDAQ
- Currency
- USD
Virax Biolabs Group Limited VRAX:NASDAQ stock context
VRAX:NASDAQ is the primary listing for Virax Biolabs Group Limited, a public company operating in the US market. With a market capitalization of around $3.02 million, Virax is dedicated to creating innovative healthcare solutions. The company is actively involved in various developments and initiatives within the healthcare sector, reflecting its commitment to addressing emerging health challenges. Recent news and filings may provide insights into its strategic direction and market positioning.
Research Virax Biolabs Group Limited
Virax Biolabs Group Limited investor report
Review AI stock analysis and investor report context for VRAX:NASDAQ.
Virax Biolabs Group Limited company profile
View the public company page for Virax Biolabs Group Limited on 6ix.
Virax Biolabs Group Limited news
Read company news and market updates connected to Virax Biolabs Group Limited.
Virax Biolabs Group Limited investor events
Find investor webinars, events, and replay context for Virax Biolabs Group Limited.